Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use

International Journal of Cancer

Volumn 118, Issue 11, 2006, Pages 2827-2831

  Vamre, Tone B Aaman ^a   Stalsberg, Helge ^a   Thomas, David B ^b   Berry, G ^c   Maclennan, R ^c   Shearman, R ^c   Jelihovsky, T ^c   Booth, J Cooper ^c   Molina, R ^d,e   Martinez, L ^d,e   Salas, O ^d,e   Dabacens, A ^d,e   Zhiheng, Cheng ^f   Yun, Tao ^f   Wei, Hu Yong ^f   Cuadros, A ^g   Aristizabal, N ^g   Ebeling, K ^h   Nishan, P ^h   Kunde, D ^h   Modan, B ⁱ   Ron, E ⁱ   Alfandary, E ⁱ   Mati, J G ^j   Kenya, P ^j   Kungu, A ^j   Gatei, D ^j   Cuevas, H Rodriguez ^k   Salazar, S Benavides ^k   Palet, A ^k   Ontiveros, P ^k   Apelo, R A ^l   De La Cruz, J R ^l   Baens, J ^l   Javier, B ^l   Silpisornkosol, Suporn ^m   Pardthaisong, Tieng ^m   Martin, Nimit ^m   Theetranont, Choti ^m   Boosiri, Banpot ⁿ   Chutivongse, Supawat ⁿ   Virutamasen, Pramuan ⁿ   Wongsrichanalai, Chansuda ⁿ   Jimakorn, Prasarn ⁿ   Koetsawang, Supom ^o   Rachawat, Daungdao ^o   Chantarakul, Nivat ^o   Ray, R M ^b   Noonan, E A ^b   Holck, S ^p   more..

^a UNIVERSITY OF TROMSØ   (Norway)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^e HOSPITAL DEL SALVADOR   (Chile)

^f SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^g Hospital Universitario   (Colombia)

^h Saxonian Academy of Sciences   (Germany)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j UNIVERSITY OF NAIROBI   (Kenya)

^k SECRETARÍA DE SALUD   (Mexico)

^l UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^m Faculty of Medicine Chiang Mai University   (Thailand)

ⁿ CHULALONGKORN UNIVERSITY   (Thailand)

^o MAHIDOL UNIVERSITY   (Thailand)

^p WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

Ductal carcinoma in situ; Ductal hyperplasia; Extra tumoral breast tissue; Oral contraceptives; Risk factors

Indexed keywords

ORAL CONTRACEPTIVE AGENT; STEROID;

ARTICLE; BREAST; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER PATIENT; CANCER RISK; CYST; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; METAPLASIA; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; ODDS RATIO; PREVALENCE;

EID: 33646367649     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21697     Document Type: Article

References (28)

1. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-ages women: a study of 110 medicolegal autopsies. Br J Cancer 1987;56:814-19.
2. Schnitt SJ. Benign breast disease and breast cancer risk. Morphology and beyond. Am J Surg Pathol 2003;27:836-41.
3. Ernster VL. The epidemiology of benign breast disease. Epidemol Rev 1981;3:184-202.
4. Kelsey JL, Gammon MD. John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
5. Lakhani SR, Chaggar R, Davies S, Jones C, Collins N, Odel C, Stratton MR, O'Hare MJ. Genetic alterations in "normal" luminal and myoepithelial cells of the breast. J Pathol 1999;189:496-503.
6. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiologic studies. Lancet 1996;347:1713-27.
7. Miller N, McPherson K, Jones L, Vessey M. Histopathology of breast cancer in young women in relation to use of oral contraceptives. J Clin Pathol 1989;42:387-90.
8. Hulman G, Trowbridge P, Taylor CN, Chilvers CED, Sloane JP, Members of the U.K. National Case-Control Study Group. Oral contraceptive use and histopathology of cancerous breasts in young women. J Pathol 1992;167:407-11.
9. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990;61:110-19.
10. Stalsberg H, Thomas DB, Noonan EA. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Int J Cancer 1989;44:399-409.
11. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
12. Aaman TB, Stalsberg H, Thomas DB. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. Int J Cancer 1997;71:333-9.
13. SAS Institute Inc. SAS language and procedures: usage, version 6. Cary, NC: SAS Institute Inc., 1989. 638p.
14. Black MM, Chabon AB. In situ carcinoma of the breast. Pathol Annu 1969;4:185-210.
15. LiVolsi VA, Stadel BV, Kelsey JK, Holford TR, White C. Fibrocystic breast disease in oral-contraceptive users: a histopathological evaluation of epithelial atypia. N Engl J Med 1987;299:381-5.
16. Pastides H, Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Goldenberg IS. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer Inst 1983;71:5-9.
17. Berkowitz GS, Kelsey JL, LiVolsi VA, Merino MJ, Holford TR, Hildreth NG, Ort S, O'Connor TZ, White C. Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer 1984;34:443-9.
18. Hsieh C, Crosson AW, Walker AM, Trapido EJ, MacMahon B. Oral contraceptive use and fibrocystic breast disease of different histopathologic classification. J Natl Cancer Inst 1984;72:285-90.
19. Haagensen CD. The relationship of gross cystic disease of the breast and carcinoma. Ann Surg 1977;185:375-6.
20. Rohan TH, Miller AB. A cohort study of oral contraceptive use and risk of benign breast disease. Int J Cancer 1999;82:191-6.
21. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996;74:129-35.
22. Jones C, Merrett S, Thomas VA, Barker TH, Lakhani SR. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 2003;199:152-6.
23. Anderson E, Clarke RB, Howell A. Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis. Endocr-Relat Cancer 1997;4:23-33.
24. Boecker W, Buerger H, Schmitz K, Ellis IA, van Dienst PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 2001;195:415-21.
25. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003;5:313-19.
26. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005;29:734-46.
27. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005;205:248-54.
28. Aaman TB, Stalsberg H, Thomas DB. The WHO Collaborative Study Of Neoplasia and Steroid Contraceptives. Extra-tumoral breast tissue in breast-cancer patients: variations with a family history of breast cancer. Int J Cancer (Pred Oncol) 1998;79:39-43.